SUGAPILL-M 500
MRP: 1,800
Packaging: 10x15
Pack Type: tablet
Composition:
Vildagliptin 50mg + Metformin 500mg Film Coated
Indication:
Type-2 Diabetes.
Description:
This film-coated tablet combines Vildagliptin 50 mg, a Dipeptidyl Peptidase-4 (DPP-4) inhibitor, with Metformin Hydrochloride 500 mg, a biguanide, for effective management of type 2 diabetes mellitus.
Vildagliptin enhances blood glucose control by increasing incretin hormones that stimulate insulin secretion and suppress glucagon release. Metformin works by reducing hepatic glucose production and increasing peripheral insulin sensitivity. Together, they improve glycemic control through complementary mechanisms.
The film coating enhances patient compliance by reducing gastrointestinal side effects often associated with Metformin.
Tags:
- Dual action improves blood glucose control
- Controls fasting and post-meal blood sugar
- Reduces insulin resistance and liver glucose output
- Low risk of hypoglycemia when used properly
- Film-coated for better gastrointestinal tolerance
Usage Information
Dosage
Take one tablet once or twice daily with meals Swallow whole with water; do not crush or chew Follow doctor’s advice on dosing and monitoring Monitor blood sugar regularly
Side Effects
Mild gastrointestinal symptoms (nausea, diarrhea) Headache, dizziness Hypoglycemia risk, especially if combined with other drugs Rare but serious: lactic acidosis, pancreatitis
Contraindications
Type 1 diabetes or diabetic ketoacidosis Severe kidney or liver disease Allergy to Vildagliptin or Metformin Conditions increasing lactic acidosis risk Pregnancy and breastfeeding unless advised by a healthcare provider
Availability
Vildagliptin Metformin 500mg, Vildagliptin 50mg Metformin combo, Type 2 diabetes treatment, Oral antidiabetic tablet, DPP-4 inhibitor with Metformin